litlas
ログインアカウント作成

Alexandra Léary

2006–2025 年に発表

別表記
Alexandra Leary
143
論文数
21,562
被引用数
62
h 指数
138
i10 指数

被引用数

Alexandra Léary の年別被引用数2000 年: 被引用 1 件2006 年: 被引用 1 件2007 年: 被引用 4 件2008 年: 被引用 8 件2010 年: 被引用 10 件2011 年: 被引用 10 件2012 年: 被引用 10 件2013 年: 被引用 9 件2014 年: 被引用 8 件2015 年: 被引用 17 件2016 年: 被引用 57 件2017 年: 被引用 92 件2018 年: 被引用 152 件2019 年: 被引用 725 件2020 年: 被引用 1,132 件2021 年: 被引用 1,126 件2022 年: 被引用 1,156 件2023 年: 被引用 986 件2024 年: 被引用 1,682 件2025 年: 被引用 893 件2026 年: 被引用 30 件2001〜2005 年は被引用が無いため表示していません2009 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,938 件、この内訳の 19.4%中国: 引用元論文 1,283 件、この内訳の 12.9%イギリス: 引用元論文 710 件、この内訳の 7.1%イタリア: 引用元論文 709 件、この内訳の 7.1%フランス: 引用元論文 542 件、この内訳の 5.4%ドイツ: 引用元論文 419 件、この内訳の 4.2%カナダ: 引用元論文 405 件、この内訳の 4.1%スペイン: 引用元論文 395 件、この内訳の 4%日本: 引用元論文 298 件、この内訳の 3%オランダ: 引用元論文 281 件、この内訳の 2.8%オーストラリア: 引用元論文 275 件、この内訳の 2.8%ベルギー: 引用元論文 194 件、この内訳の 1.9%
0%19.4%その他 25.3%

機関

分野

  • Medicine72.8%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Immunology and Microbiology3.3%
  • Computer Science1.2%
  • Materials Science0.4%
  • Neuroscience0.4%
  • その他1.5%

トピック

  • Ovarian cancer diagnosis and treatment9.7%
  • PARP inhibition in cancer therapy9.6%
  • Endometrial and Cervical Cancer Treatments7.4%
  • Cancer Immunotherapy and Biomarkers5.3%
  • DNA Repair Mechanisms3.3%
  • BRCA gene mutations in cancer2.7%
  • その他62%

共著者

全論文

検索で開く
  1. Maintenance Olaparib in Patients With Newly Diagnosed Advanced Ovarian Cancer

    著者: Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Susana Banerjee, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, Elizabeth Lowe, Ralph Bloomfield, Paul DiSilvestro - New England Journal of Medicine 2018 被引用: 2,839

  2. Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Robert L. Coleman, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Léary, Robert W. Holloway, Margarita Amenedo, Peter C.C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Jesús García-Donás, Elizabeth M. Swisher, Anne Floquet, Gottfried E. Konecny, Iain A. McNeish, Clare L. Scott, T. Cameron, Lara Maloney, Jeff Isaacson, Sandra Goble, Caroline A. Grace, Thomas C. Harding, Mitch Raponi, James Sun, Kevin Lin, Heidi Giordano, Jonathan A. Ledermann, Martin Buck, Andrew Dean, Michael Friedländer, Jeffrey C. Goh, Paul R. Harnett, Ganessan Kichenadasse, Clare L. Scott, Hannelore Denys, Luc Dirix, Ignace Vergote, Laurie Elit, Prafull Ghatage, Amit M. Oza, Marie Plante, Diane Provencher, Johanne I. Weberpals, Stephen Welch, Anne Floquet, Laurence Gladieff, Florence Joly, Alexandra Léary, Alain Lortholary, Jean‐Pierre Lotz, Jacques Médioni, Olivier Trédan, Benoît You, Ayşe Balat, Claudia Hänle, Petra Krabisch, Tanja Neunhöffer, Martin Pölcher, Pauline Wimberger, A Amit, Svetlana Kovel, Michelle Leviov, Tamar Safra, Ronnie Shapira‐Frommer, Salomon M. Stemmer, Alessandra Bologna, Nicoletta Colombo, Domenica Lorusso, Sandro Pignata, Roberto Sabbatini, Giovanni Scambia, Stefano Tamberi, Claudio Zamagni, Peter C.C. Fong, Anne O’Donnell, Margarita Amenedo, A. Casado Herráez, Jesús García-Donás, E.M. Guerra, Ana Oaknin, Isabel Palacio, Ignacio Romero, A Sanchez, Susana Banerjee, Andrew R. Clamp, Yvette Drew, Hani Gabra, D Jackson, JA Ledermann, Iain A. McNeish, C. A. Parkinson, Melanie Powell, Carol Aghajanian ほか 17 名 - The Lancet 2017 被引用: 1,704

  3. Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

    著者: Hyun Cheol Chung, Willeke Ros, Jean‐Pierre Delord, Ruth Perets, Antoîne Italiano, Ronnie Shapira‐Frommer, Lyudmila Manzuk, Sarina A. Piha‐Paul, Lei Xu, Susan Zeigenfuss, Scott K. Pruitt, Alexandra Léary - Journal of Clinical Oncology 2019 被引用: 1,056

  4. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial

    著者: Paul DiSilvestro, Susana Banerjee, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, John McNamara, Elizabeth Lowe, Mei-Lin Ah-See, Kathleen N. Moore, on behalf of the SOLO1 Investigators - Journal of Clinical Oncology 2022 被引用: 475

  5. Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    著者: Alicia León‐Castillo, Stephanie M. de Boer, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Hans W. Nijman, Naveena Singh, Pamela M. Pollock, Paul Bessette, Anthony Fyles, Christine Haie-Méder, Vincent T.H.B.M. Smit, Richard J. Edmondson, Hein Putter, Henry C Kitchener, Emma J. Crosbie, Marco de Bruyn, Remi A. Nout, Nanda Horeweg, Carien L. Creutzberg, Tjalling Bosse - Journal of Clinical Oncology 2020 被引用: 837

  6. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study

    著者: Éric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann, Amit M. Oza, Rebecca Kristeleit, Isabelle-Laure Ray-Coquard, Gary Richardson, Cristiana Sessa, Kan Yonemori, Susana Banerjee, Alexandra Léary, Anna V. Tinker, Kyung Hae Jung, Radosław Mądry, Sang‐Yoon Park, Charles Anderson, Fabian Zohren, Ross Stewart, Caimiao Wei, Samuel S. Dychter, Bradley J. Monk - The Lancet Oncology 2021 被引用: 405

  7. Newly diagnosed and relapsed epithelial ovarian cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

    著者: Antonio González-Martı́n, Philipp Harter, Alexandra Léary, Domenica Lorusso, Rowan Miller, Bhavana Pothuri, Isabelle Ray‐Coquard, David S.P. Tan, E. Bellet, Ana Oaknin, Jonathan A. Ledermann - Annals of Oncology 2023 被引用: 388

  8. Olaparib plus bevacizumab first-line maintenance in ovarian cancer: final overall survival results from the PAOLA-1/ENGOT-ov25 trial

    著者: I. Ray-Coquard, Alexandra Léary, Sandro Pignata, Claire Cropet, Antonio González-Martı́n, Christian Marth, Shoji Nagao, Ignace Vergote, Nicoletta Colombo, Johanna Mäenpää, Frédèric Selle, Jalid Sehouli, Domenica Lorusso, Eva María Guerra Alia, Gerhard Bogner, Hiroyuki Yoshida, C. Lefeuvre-Plesse, Paul Buderath, Anna Maria Mosconi, A. Lortholary, Alexander Burges, J. Medioni, Ayşe Balat, Manuel Rodrigues, Tjoung‐Won Park‐Simon, Coraline Dubot, Dominik Denschlag, Benoît You, Éric Pujade-Lauraine, Philipp Harter - Annals of Oncology 2023 被引用: 339

  9. Endometrial cancer

    著者: Philippe Morice, Alexandra Léary, Carien L. Creutzberg, Nadeem R. Abu‐Rustum, Émile Daraï - The Lancet 2015 被引用: 1,522

  10. Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Susana Banerjee, Kathleen N Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Amit Oza, Antonio González-Martín, Carol Aghajanian, William H Bradley, Eileen Holmes, Elizabeth S Lowe, Paul DiSilvestro - The Lancet Oncology 2021 被引用: 371

  11. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial

    著者: Ana Oaknin, Laurence Gladieff, Jerónimo Martínez-García, Guillermo Villacampa, Munetaka Takekuma, Ugo De Giorgi, Kristina Lindemann, Linn Woelber, Nicoletta Colombo, Linda Duska, Alexandra Léary, Ana Godoy-Ortíz, Shin Nishio, Antoine Angelergues, María Jesús Rubio, Lorena Fariñas-Madrid, Satoshi Yamaguchi, Domenica Lorusso, Isabelle Ray‐Coquard, Luís Manso, Florence Joly, Jesús Alarcón, Philippe Follana, Ignacio Romero, Coriolan Lebreton, José Alejandro Pérez Fidalgo, Mayu Yunokawa, Hanna Dahlstrand, Véronique D’Hondt, Leslie M. Randall, Sophie Abadie‐Lacourtoisie, Claudia Andreetta, Nerea Anzizar, Daiseuke Aoki, Maria-Pilar Barretina-Ginesta, Marco Johannes Battista, Charlotte Béllier, Anne Gry Bentzen, Dominique Berton, Bertrand Billemont, Line Bjørge, Maria Bjurberg, Destin Black, Alessandra Bologna, Elena Ioana Braicu, Cláudia Casanova, Radoslav Chekerov, Annick Chevalier, Juan Cueva, Bastian Czogalla, Nicolas Delanoy, Dominik Denschlag, Oscar Derke, Michael Eichbaum, Takayuki Enomoto, Carmen Esteban, Michel Fabbro, Tanja Fehm, Annamaria Ferrero, Markus C. Fleisch, Anne Floquet, Antonio Frassoldati, Lydia Gaba, Angiolo Gadducci, Yolanda García García, Elena Geuna, Eva Guerra, Lars Hanker, Anne‐Claire Hardy‐Bessard, Philipp Harter, Kosei Hasegawa, Kristina Hellman, Ana Herrero, Felix Hilpert, Dionyssios Katsaros, M. Koegel, Anthoula Koliadi, Jean‐Emmanuel Kurtz, Bjoern Lampe, Andrea Alberto Lissoni, Alain Lortholary, Giorgia Mangili, Laura Mansi, Frederik Marmé, Cara Mathews, William Mina, Shinichiro Minobe, Katherine Moxley, Shoji Nagao, Ornella Nicoletto, Koji Nishino, Hiroshi Nishio, Shin Nishio, Ana Oaknin, Michaela Onstad, Beatriz Pardo, José Alejandro Pérez Fidalgo, Carmela Pisano, Andrés Poveda, Julia Caroline Radosa ほか 21 名 - The Lancet 2023 被引用: 209

  12. Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial

    著者: Elizabeth M. Swisher, Kevin Lin, Amit M. Oza, Clare L. Scott, Heidi Giordano, James Sun, Gottfried E. Konecny, Robert L. Coleman, Anna V. Tinker, David M. O’Malley, Rebecca Kristeleit, Ling Ma, Katherine M. Bell‐McGuinn, James D. Brenton, Janiel M. Cragun, Ana Oaknin, Isabelle Ray‐Coquard, Maria I. Harrell, Elaina Mann, Scott H. Kaufmann, Anne Floquet, Alexandra Léary, Thomas C. Harding, Sandra Goble, Lara Maloney, Jeff Isaacson, Andrew R. Allen, Lindsey Rolfe, Roman Yelensky, Mitch Raponi, Iain A. McNeish - The Lancet Oncology 2016 被引用: 1,200

  13. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer

    著者: Rowan Miller, Alexandra Léary, Clare L. Scott, Violeta Serra, Christopher J. Lord, David D.L. Bowtell, David K. Chang, Dale W. Garsed, Jos Jonkers, Jonathan A. Ledermann, Serena Nik‐Zainal, Isabelle Ray‐Coquard, Sohrab P. Shah, Xavier Matías‐Guiu, Elizabeth M. Swisher, Lucy Yates - Annals of Oncology 2020 被引用: 481

  14. ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease

    著者: Jonathan A. Ledermann, Xavier Matías‐Guiu, Frédéric Amant, Nicole Concin, Ben Davidson, Christina Fotopoulou, Antonio González-Martı́n, Charlie Gourley, Alexandra Léary, Domenica Lorusso, Susana Banerjee, Luis Chiva, David Cibula, Nicoletta Colombo, Sabrina Croce, Ane Gerda Zahl Eriksson, Claire Falandry, D. Fischerová, Philipp Harter, Florence Joly, Conxi Lázaro, C.A.R. Lok, Sven� Mahner, Frederik Marmé, Christian Marth, W. Glenn McCluggage, Iain A. McNeish, Philippe Morice, Shibani Nicum, Ana Oaknin, José Alejandro Pérez Fidalgo, Sandro Pignata, Pedro T. Ramírez, Isabelle Ray‐Coquard, Ignacio Romero, Giovanni Scambia, Jalid Sehouli, Ronnie Shapira‐Frommer, Sudha Sundar, David S.P. Tan, Çağatay Taşkıran, Willemien J. van Driel, Ignace Vergote, François Planchamp, Cristiana Sessa, Anna Fagotti - Annals of Oncology 2024 被引用: 284

  15. Prognostic refinement of NSMP high-risk endometrial cancers using oestrogen receptor immunohistochemistry

    著者: Lisa Vermij, Jan J. Jobsen, Alicia León‐Castillo, Mariël Brinkhuis, Suzan Roothaan, Melanie Powell, Stephanie M. de Boer, Pearly Khaw, Linda Mileshkin, Anthony Fyles, Alexandra Léary, Catherine Genestie, Ina M. Jürgenliemk‐Schulz, Emma J. Crosbie, Helen Mackay, Hans W. Nijman, Remi A. Nout, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, Stephanie M. de Boer - British Journal of Cancer 2023 被引用: 162

  16. Interpretable deep learning model to predict the molecular classification of endometrial cancer from haematoxylin and eosin-stained whole-slide images: a combined analysis of the PORTEC randomised trials and clinical cohorts

    著者: Sarah Fremond, Sonali Andani, Jurriaan Barkey Wolf, Jouke Dijkstra, Sinéad Melsbach, Jan J. Jobsen, Mariël Brinkhuis, Suzan Roothaan, Ina J. Jürgenliemk-Schulz, Ludy Lutgens, Remi A. Nout, Elzbieta M. van der Steen‐Banasik, Stephanie M. de Boer, Melanie Powell, Naveena Singh, Linda Mileshkin, Helen Mackay, Alexandra Léary, Hans W. Nijman, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Nanda Horeweg, Viktor H. Koelzer, Tjalling Bosse - The Lancet Digital Health 2022 被引用: 124

  17. Ovarian Cancer: A Heterogeneous Disease

    著者: Myriam Kossaï, Alexandra Léary, Jean‐Yves Scoazec, Catherine Genestie - Pathobiology 2017 被引用: 411

  18. openalex_id:w4226283539

    著者: Susana Banerjee, Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Eileen Holmes, Elizabeth Lowe, Paul DiSilvestro 被引用: 185

  19. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients

    著者: Nanda Horeweg, Hagma H. Workel, Dominik Loiero, David N. Church, Lisa Vermij, Alicia León‐Castillo, Ricki T. Krog, Stephanie M. de Boer, Remi A. Nout, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Naveena Singh, Ina M. Jürgenliemk‐Schulz, Vincent T.H.B.M. Smit, Carien L. Creutzberg, Viktor H. Koelzer, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn, Nanda Horeweg, David N. Church, Stephanie M. de Boer, Remi A. Nout, Melanie Powell, Linda Mileshkin, Helen Mackay, Alexandra Léary, Naveena Singh, Carien L. Creutzberg, Hans W. Nijman, Tjalling Bosse, Marco de Bruyn - Nature Communications 2022 被引用: 144

  20. p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial

    著者: Lisa Vermij, Alicia León‐Castillo, Naveena Singh, Melanie Powell, Richard J. Edmondson, Catherine Genestie, Pearly Khaw, Jan Pyman, C. Meg McLachlin, Prafull Ghatage, Stephanie M. de Boer, Hans W. Nijman, Vincent T.H.B.M. Smit, Emma J. Crosbie, Alexandra Léary, Carien L. Creutzberg, Nanda Horeweg, Tjalling Bosse, Nanda Horeweg, Stephanie M. de Boer, Carien L. Creutzberg, Tjalling Bosse, Vincent T.H.B.M. Smit, Judith R. Kroep, Remi A. Nout, Hans W. Nijman, Marco de Bruyn, Melanie Powell, Naveena Singh, H. Kitchener, Emma J. Crosbie, Richard J. Edmondson, David N. Church, Alexandra Léary, Linda Mileshkin, Pamela M. Pollock, Helen Mackay - Modern Pathology 2022 被引用: 161

  21. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative

    著者: Ellen Stelloo, Tjalling Bosse, Remi A. Nout, Helen Mackay, David N. Church, Hans W. Nijman, Alexandra Léary, Richard J. Edmondson, Melanie Powell, Emma J. Crosbie, Henry C Kitchener, Linda Mileshkin, Pamela M. Pollock, Vincent T.H.B.M. Smit, Carien L. Creutzberg - Modern Pathology 2015 被引用: 490

  22. Myelodysplastic syndrome and acute myeloid leukaemia in patients treated with PARP inhibitors: a safety meta-analysis of randomised controlled trials and a retrospective study of the WHO pharmacovigilance database

    著者: Pierre‐Marie Morice, Alexandra Léary, Charles Dolladille, Basile Chrétien, Laurent Poulain, Antonio González-Martı́n, Kathleen N. Moore, Eileen M. O’Reilly, Isabelle Ray‐Coquard, Joachim Alexandre - The Lancet Haematology 2020 被引用: 244

  23. Molecular and clinical determinants of response and resistance to rucaparib for recurrent ovarian cancer treatment in ARIEL2 (Parts 1 and 2)

    著者: Elizabeth M. Swisher, Tanya T. Kwan, Amit M. Oza, Anna V. Tinker, Isabelle Ray‐Coquard, Ana Oaknin, Robert L. Coleman, Carol Aghajanian, Gottfried E. Konecny, David M. O’Malley, Alexandra Léary, Diane Provencher, Stephen Welch, Lee-may Chen, Andrea E. Wahner Hendrickson, Ling Ma, Prafull Ghatage, Rebecca Kristeleit, Oliver Dorigo, Ashan Musafer, Scott H. Kaufmann, Julia A. Elvin, Douglas I. Lin, Setsuko K. Chambers, Erin Dominy, Lan-Thanh Vo, Sandra Goble, Lara Maloney, Heidi Giordano, Thomas Harding, Alexander Dobrovic, Clare L. Scott, Kevin Lin, Iain A. McNeish - Nature Communications 2021 被引用: 205

  24. Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial

    著者: Jean‐Emmanuel Kurtz, Éric Pujade-Lauraine, Ana Oaknin, Lisa Belin, Katharina Leitner, David Cibula, Hannelore Denys, Ora Rosengarten, Manuel Rodrigues, Nikolaus de Gregorio, Jerónimo Martínez, Edgar Petru, Roman Kocián, Ignace Vergote, Patricia Pautier, Barbara Schmalfeldt, Lydia Gaba, Stephan Polterauer, Marie‐Ange Mouret‐Reynier, Jalid Sehouli, Cristina Churruca, Frédèric Selle, Florence Joly, Véronique D’Hondt, Émilie Bultot-Boissier, Coriolan Lebreton, Jean‐Pierre Lotz, Rémy Largillier, Pierre‐Etienne Heudel, Florian Heitz, on behalf of the ATALANTE/ENGOT-ov29 Investigators, Jean‐Emmanuel Kurtz, Sophie Abadie‐Lacourtoisie, Cyril Abdeddaim, J. Alexandre, P. Augereau, D. Avenin, M. Azémar, Nabil Baba-Hamed, Olivia Bally, Jérôme Barrière, Fernando Bazán, Dominique Berton, Nathalie Bonichon-Lamichhane, Nathalie Bonnin, Elouen Boughalem, R. Boustany Grenier, Pierre-Emmanuel Brachet, Fabien Brocard, Émilie Bultot-Boissier, Maria Cappiello-Bataller, H. Castanie, L. Chaigneau, Camille Chakiba, Dorothée Chocteau-Bouju, Pierre Combe, Aurélie Comte, Elodie Coquan, Cristina Costan, P. Cottu, L. Crouzet, H. Curé, Jérôme Dauba, Hussain Dawood, Laure De Cock, T. De La Motte Rouge, C. Debelleix, Catherine Delbaldo, Martin Demarchi, Marion Deslandres, Raymond Despax, Véronique D’Hondt, Anne Françoise DILLIES-LEGRAIN, A Donnadieu, C. Dubot, Jean Marc Extra, Michel Fabbro, Claire Falandry, F. Fiteni, Anne Floquet, Philippe Follana, Jean‐Sébastien Frenel, G. Freyer, D. Garbay-Decoopman, Céline Gavoille, V. Girre, Laurence Gladieff, F. Goldwasser, Alain Gratet, Jean‐Christophe Grenier, Anne‐Claire Hardy‐Bessard, Pierre‐Etienne Heudel, Florence Joly, A. Jouinot, Emilie Kalbacher, Marie‐Christine Kaminsky, Laurence Lancry-Lecomte, R. Largillier, Fanny Le Du, Alexandra Léary ほか 89 名 - Journal of Clinical Oncology 2023 被引用: 103